ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition

8Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Some cancer cells elongate their telomeres through the ALT (alternative lengthening of telomeres) pathway, which is based on homologous recombination for the addition of telomere repeats without telomerase activity. General control non-derepressible 5 (GCN5) and P300/CBP-associated factor (PCAF), two homologous lysine acetyltransferases, exert opposite effects on the ALT pathway, inhibiting or favoring it respectively. Here we show that ALT cells are particularly sensitive to the inhibition of acetyltransferases activities using Anacardic Acid (AA). AA treatment recapitulates the effect of PCAF knockdown on several ALT features, suggesting that AA decreased the ALT mechanism through the inhibition of lysine transferase activity of PCAF, but not that of GCN5. Furthermore, AA specifically sensitizes human ALT cells to radiation as compared to telomerase-positive cells suggesting that the inhibition of lysine acetyltransferases activity may be used to increase the radiotherapy efficiency against ALT cancers.

Cite

CITATION STYLE

APA

Bakhos-Douaihy, D., Desmaze, C., Jeitany, M., Gauthier, L. R., Biard, D., Junier, M. P., … Boussin, F. D. (2019). ALT cancer cells are specifically sensitive to lysine acetyl transferase inhibition. Oncotarget, 10(7), 773–784. https://doi.org/10.18632/oncotarget.26616

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free